12.11.2020 Geratherm Medical AG  DE0005495626

DGAP-Adhoc: Geratherm Medical AG: Business performance from 1 January to 30 September 2020


 

DGAP-Ad-hoc: Geratherm Medical AG / Key word(s): 9 Month figures
Geratherm Medical AG: Business performance from 1 January to 30 September 2020

12-Nov-2020 / 15:21 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of an insider information pursuant to article 17 of MAR
transmitted by DGAP - a service of EQS Group AG

Geratherm Medical AG, Geratal, November 12, 2020

Business performance from 1 January to 30 September 2020

- Continuing Strong international demand for Geratherm medical devices

- Sales revenues EUR 19.8 million +28.7 %, QIII +27.3 %

- Gross result for the period under review (EBITDA) EUR 3.053 million +43.5 %,
 
  QIII EUR 1.001 million +61.8 %

- Operating result (EBIT) EUR 2.140 million +71.6 %

            QIII EUR 0.686 million +125.9 %

- EBIT margin 10.8 %, QIII +11.6 %

- Results from ordinary business activities EUR 2.054 million +64.9 %

            QIII EUR 0.651 million +126.0 %

- Earnings per share EUR 0.31 (2019: EUR 0.15), QIII EUR 0.10

The business development of the Geratherm Medical AG continues to be very positive. In the III quarter, we managed to increase sales by 27.3 %. Our profits reported in the III quarter have more than doubled.

For the IV. quarter of the current financial year, we expect a significantly stronger sales and earnings performance compared to the previous year. The IV. quarter is likely to gain further momentum compared with the previous quarters. The capacities for the production of clinical thermometers are currently already fully utilized until July 2021.

The quarterly report on the 9-month financial statements will be published on November 19, 2020.

Geratherm Medical AG
Firmensitz: Fahrenheitstraße 1, 99331 Geratal
Registergericht: Amtsgericht Jena, HRB 111272
Vorstand: Dr. Gert Frank
Aufsichtsratsvorsitzender: Dipl.-Kfm. Rudolf Bröcker
Tel. 036205/98 0; Fax: 036205/98 115
E-Mail: [email protected]
www.geratherm.com


Short company profil:
Geratherm Medical is an internationally operating medical products enterprise with the business areas Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Our company's roots are in temperature measurement in the medical sphere. In this business area we offer a broad spectrum of products, most of which have unique selling points. We supply our customers/patients with high-quality products ranging from thermometers to complex warming systems for use in the operating theatre and by emergency rescue services and MR Diagnostic Incubator Systems for premature babies and newborns. In the Cardio business area we concentrate on the development of products for the detection of atrial fibrillation as a measure to prevent strokes. The Respiratory segment develops and markets products for the assessment of pulmonary function. In all mainly business areas, Geratherm has patent-protected basic technologies at its disposal. We regard ourselves as a research-based medical products company with a clear focus on medical diagnostic devices that generate vital data. Geratherm shares have been listed in the Prime Standard segment of the Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues to be represented in the German Entrepreneurial Index and in the German Healthcare Index.

 

 




Contact:
Dr. Gert Frank

12-Nov-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Geratherm Medical AG
Fahrenheitstraße 1
99331 Geratal
Germany
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-1 15
E-mail: [email protected]
Internet: www.geratherm.com
ISIN: DE0005495626
WKN: 549562
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1147785

 
End of Announcement DGAP News Service

1147785  12-Nov-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1147785&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2015 2016 2017 2018 2019 2020 2021e
Umsatzerlöse1 21,59 21,41 21,03 21,52 19,85 27,47 28,90
EBITDA1,2 3,42 3,71 1,77 2,80 2,35 4,35 5,00
EBITDA-Marge3 15,84 17,33 8,42 13,01 11,84 15,84 17,30
EBIT1,4 2,53 2,54 0,63 1,99 1,05 3,04 3,60
EBIT-Marge5 11,72 11,86 3,00 9,25 5,29 11,07 12,46
Jahresüberschuss1 2,39 2,25 0,22 0,83 0,29 1,90 2,50
Netto-Marge6 11,07 10,51 1,05 3,86 1,46 6,92 8,65
Cashflow1,7 3,77 0,79 2,47 1,35 1,54 3,92 4,55
Ergebnis je Aktie8 0,55 0,45 0,14 0,23 0,11 0,41 0,48
Dividende8 0,50 0,50 0,47 0,40 0,25 0,40 0,42
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

INVESTOR-INFORMATIONEN
©boersengefluester.de
Geratherm Medical
WKN Kurs in € Einschätzung Börsenwert in Mio. €
549562 9,220 Kaufen 45,64
KGV 2022e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
13,76 25,11 0,55 27,69
KBV KCV KUV EV/EBITDA
2,54 11,66 1,66 10,30
Dividende '20 in € Dividende '21e in € Div.-Rendite '21e
in %
Hauptversammlung
0,40 0,42 4,56 11.06.2021
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
20.05.2021 25.08.2021 24.11.2021 28.04.2021
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-5,60% -16,11% -15,41% -17,68%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Geratherm Medical AG  ISIN: DE0005495626 können Sie bei DGAP abrufen

Medtech , 549562 , GME , XETR:GME